The stock of Puma Biotechnology Inc (PBYI) closed the regular trading session at $2.33, gaining 4.95% from the previous trading session. On the last check,
On January 12, Puma Biotechnology Inc. (PBYI) announced that the NCCN Clinical Practice Guideline for the treatment of breast cancer has been updated. The update
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.